US Patent Issued to Yoshikazu YONEMITSU, GAIA BioMedicine on June 17 for "Highly active NK cell and use thereof" (Japanese Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,817, issued on June 17, was assigned to Yoshikazu YONEMITSU (Fukuoka, Japan) and GAIA BioMedicine Inc. (Fukuoka, Japan).

"Highly active NK cell and use thereof" was invented by Yoshikazu Yonemitsu (Fukuoka, Japan), Yui Harada (Fukuoka, Japan) and Koji Teraishi (Fukuoka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "An NK cell showing higher cytotoxic activity is provided. An object of the present invention is to provide a pharmaceutical composition for NK cell therapies expected to be highly effective. The present invention provides an NK cell having the following characteristics of (1) and (2) or a population thereof: (1) the NK cell is CD16...